ICD-10-CM Billable Code

M61.122

Myositis ossificans progressiva, left upper arm

Clinical Classification Guidelines

Medical Intelligence & Overview

Myositis ossificans progressiva, also known as heterotopic ossification, is a rare condition characterized by abnormal bone formation in soft tissues like muscles. When affecting the left upper arm, it can lead to pain, swelling, and restricted movement. This condition can develop following trauma or injury, but in some cases, it appears without any obvious cause. Proper awareness of its symptoms, causes, diagnosis, and treatment options can aid in management and improve quality of life.

Causes & Symptoms

Clinical Causes: Previous trauma or injury to the upper arm, such as fractures, bruises, or surgeries Repeated or severe muscle damage leading to abnormal healing processes Certain genetic conditions that predispose individuals to abnormal bone formation Spontaneous development without an apparent cause (idiopathic cases) In some cases, neurogenic myositis ossificans, associated with nerve injuries Persistent inflammation or inadequate initial treatment of soft tissue injuries

Key Symptoms: Swelling and firmness in the affected part of the upper arm Pain or tenderness around the affected area, especially during movement Reduced range of motion and stiffness in the shoulder or elbow Formation of a hard lump that might be noticeable or palpable Possible warmth or redness if inflammation is active Progressive loss of muscle function or limb movement restrictions over time

Diagnostic & Treatment

Diagnosis Path: Diagnosing myositis ossificans progressiva involves a combination of clinical examination and imaging studies. The process typically includes: - **Medical history review** to identify previous trauma or injury - **Physical examination** focusing on swelling, firmness, and range of motion - **Imaging tests** such as X-rays, which reveal abnormal bone formation in soft tissues - **Computed tomography (CT) scans** for detailed visualization of ossification - **Magnetic resonance imaging (MRI)** to assess soft tissue and rule out other conditions - **Biopsy** may be performed in rare cases to exclude malignant growths, though it is often unnecessary if imaging findings are characteristic

Treatment Protocols: Management of myositis ossificans progressiva may include various approaches, often tailored to the severity and symptoms. Common strategies are: - **Rest and activity modification** to prevent further tissue damage - **Physical therapy** aimed at maintaining joint mobility and preventing stiffness - **Medications**, such as non-steroidal anti-inflammatory drugs (NSAIDs), to reduce inflammation and pain - **Radiation therapy** in some cases to inhibit abnormal bone growth after surgical removal - **Surgical removal** of ossified tissue, considered when symptoms are severe, restricting movement, or causing pain; surgery is usually delayed until the ossification stabilizes - **Monitoring and follow-up** to detect any recurrence or progression It is important to note that early intervention can help prevent severe deformity and functional impairment.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M61.122 a billable ICD-10 code?
Yes, M61.122 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M61.122?
Clinical documentation must specify the nature of Myositis ossificans progressiva, left upper arm and any associated comorbidities for accurate reporting.

Cite this Clinical Reference